Asthma medications and control
| Subjects n | 18 |
| Asthma medications | |
| Inhaled corticosteroid | 18 (100) |
| Long-acting β2-agonist | 18 (100) |
| Long-acting anticholinergic | 7 (39) |
| Oral corticosteroid | 8 (44) |
| Leukotriene receptor antagonist | 9 (50) |
| Anti-immunoglobulin E | 1 (6) |
| Asthma control | |
| ACQ score# | 2.3±0.9 |
| AQLQ total score# | 4.6±1.2 |
| mMRC dyspnoea score# | 1.3±1.0 |
| Borg dyspnoea score# | 2.5±2.3 |
| Severe exacerbation in the previous 6 months | 9 (50) |
| Severe exacerbation in the previous year | 15 (83) |
| Emergency department visit in the previous 6 months | 1 (6) |
| Emergency department visit in the previous year | 4 (22) |
| Hospitalisation in the previous 6 months | 0 (0) |
| Hospitalisation in the previous year | 1 (6) |
Data are presented as mean±sd or n (%), unless otherwise stated. ACQ: Asthma Control Questionnaire; AQLQ: Asthma Quality of Life Questionnaire; mMRC: modified Medical Research Council. #: n=16.